MX2009004382A - Variaciones geneticas asociadas con tumores. - Google Patents
Variaciones geneticas asociadas con tumores.Info
- Publication number
- MX2009004382A MX2009004382A MX2009004382A MX2009004382A MX2009004382A MX 2009004382 A MX2009004382 A MX 2009004382A MX 2009004382 A MX2009004382 A MX 2009004382A MX 2009004382 A MX2009004382 A MX 2009004382A MX 2009004382 A MX2009004382 A MX 2009004382A
- Authority
- MX
- Mexico
- Prior art keywords
- tumors
- variations associated
- genetic variations
- diagnosing
- nucleotide
- Prior art date
Links
- 206010028980 Neoplasm Diseases 0.000 title abstract 3
- 230000007614 genetic variation Effects 0.000 title 1
- 150000001413 amino acids Chemical class 0.000 abstract 1
- 239000002773 nucleotide Substances 0.000 abstract 1
- 125000003729 nucleotide group Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/112—Disease subtyping, staging or classification
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Analytical Chemistry (AREA)
- Wood Science & Technology (AREA)
- Pathology (AREA)
- Immunology (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Hospice & Palliative Care (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Physics & Mathematics (AREA)
- General Engineering & Computer Science (AREA)
- Oncology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US86310606P | 2006-10-26 | 2006-10-26 | |
| US91781407P | 2007-05-14 | 2007-05-14 | |
| PCT/US2007/082397 WO2008070325A2 (en) | 2006-10-26 | 2007-10-24 | Genetic variations associated with tumors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2009004382A true MX2009004382A (es) | 2009-06-11 |
Family
ID=39462092
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2009004382A MX2009004382A (es) | 2006-10-26 | 2007-10-24 | Variaciones geneticas asociadas con tumores. |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US8680041B2 (enExample) |
| EP (1) | EP2089540B1 (enExample) |
| JP (1) | JP5596975B2 (enExample) |
| AU (1) | AU2007329740B2 (enExample) |
| CA (1) | CA2666057C (enExample) |
| IL (1) | IL198354A (enExample) |
| MX (1) | MX2009004382A (enExample) |
| NZ (1) | NZ576852A (enExample) |
| WO (1) | WO2008070325A2 (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ576852A (en) * | 2006-10-26 | 2012-02-24 | Genentech Inc | Genetic variations (in the phosphatidylinositol 3-kinase regulatory subunit 1 pik3r1 protein) associated with tumors and method of testing for |
| GB201001602D0 (en) | 2010-02-01 | 2010-03-17 | Cytovation As | Oligopeptidic compounds and uses therof |
| EP2554551A1 (en) * | 2011-08-03 | 2013-02-06 | Fundacio Institut mar d'Investigacions Médiques (IMIM) | Mutations in the epidermal growth factor receptor gene |
| JPWO2014017491A1 (ja) * | 2012-07-26 | 2016-07-11 | 国立研究開発法人国立がん研究センター | Ｃｅｐ５５遺伝子とｒｅｔ遺伝子との融合遺伝子 |
| KR101501826B1 (ko) * | 2013-04-05 | 2015-03-13 | 연세대학교 산학협력단 | 위암에 대한 예후 예측 모형의 제조방법 |
| WO2015161277A1 (en) * | 2014-04-18 | 2015-10-22 | Blueprint Medicines Corporation | Met fusions |
| CN108948175B (zh) * | 2018-07-23 | 2020-11-20 | 首都医科大学附属北京胸科医院 | 与人类蛋白smad2相互作用的结核蛋白及其应用 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6355623B2 (en) * | 1998-09-24 | 2002-03-12 | Hopital-Sainte-Justine | Method of treating IBD/Crohn's disease and related conditions wherein drug metabolite levels in host blood cells determine subsequent dosage |
| CA2427858A1 (en) * | 2000-11-03 | 2002-05-10 | University Of Vermont And State Agricultural College | Compositions for inhibiting grb7 |
| NZ576852A (en) * | 2006-10-26 | 2012-02-24 | Genentech Inc | Genetic variations (in the phosphatidylinositol 3-kinase regulatory subunit 1 pik3r1 protein) associated with tumors and method of testing for |
-
2007
- 2007-10-24 NZ NZ576852A patent/NZ576852A/en not_active IP Right Cessation
- 2007-10-24 MX MX2009004382A patent/MX2009004382A/es active IP Right Grant
- 2007-10-24 AU AU2007329740A patent/AU2007329740B2/en not_active Ceased
- 2007-10-24 CA CA2666057A patent/CA2666057C/en not_active Expired - Fee Related
- 2007-10-24 EP EP07871228.8A patent/EP2089540B1/en active Active
- 2007-10-24 JP JP2009534839A patent/JP5596975B2/ja active Active
- 2007-10-24 US US12/446,907 patent/US8680041B2/en active Active
- 2007-10-24 WO PCT/US2007/082397 patent/WO2008070325A2/en not_active Ceased
-
2009
- 2009-04-23 IL IL198354A patent/IL198354A/en active IP Right Grant
-
2014
- 2014-03-06 US US14/199,738 patent/US9631240B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| AU2007329740A1 (en) | 2008-06-12 |
| JP2010508025A (ja) | 2010-03-18 |
| IL198354A0 (en) | 2010-02-17 |
| JP5596975B2 (ja) | 2014-10-01 |
| AU2007329740B2 (en) | 2014-05-01 |
| US8680041B2 (en) | 2014-03-25 |
| EP2089540A2 (en) | 2009-08-19 |
| WO2008070325A2 (en) | 2008-06-12 |
| AU2007329740A2 (en) | 2009-06-18 |
| CA2666057C (en) | 2016-10-11 |
| CA2666057A1 (en) | 2008-06-12 |
| IL198354A (en) | 2014-11-30 |
| EP2089540B1 (en) | 2017-04-19 |
| NZ576852A (en) | 2012-02-24 |
| US9631240B2 (en) | 2017-04-25 |
| US20100055095A1 (en) | 2010-03-04 |
| US20150010537A1 (en) | 2015-01-08 |
| WO2008070325A3 (en) | 2009-03-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE527385T1 (de) | Mit tumoren assoziierte genetische variationen | |
| WO2010045318A3 (en) | Gene and gene expressed protein targets depicting biomarker patterns and signature sets by tumor type | |
| WO2008117314A3 (en) | Genetic variants on chr2 and chr16 as markers for use in breast cancer risk assessment, diagnosis, prognosis and treatment | |
| MX2009004522A (es) | Variantes de suceptibilidad a cancer en chr8q24.21. | |
| WO2009100188A3 (en) | Methods for detection of corn event das-59132 | |
| WO2008011519A3 (en) | Amigo-2 inhibitors for treating, diagnosing or detecting cancer | |
| MX2007012782A (es) | Metodos y acidos nucleicos para analisis de trastornos proliferativos celulares. | |
| MX2009004382A (es) | Variaciones geneticas asociadas con tumores. | |
| BRPI0912927A2 (pt) | "método de detectar um tumor independente de vegf em um indivíduo e método de tratar um tumor independente de vegf em um indivíduo" | |
| WO2009037473A3 (en) | Nucleobase characterisation | |
| MX378733B (es) | Métodos in vitro y composiciones para identificar y usarse en el tratamiento de lupus. | |
| MX2009005058A (es) | Metodos para tratar, diagnosticar o detectar cancer. | |
| PL2211180T3 (pl) | Zastosowanie białka SATB2 jako markera do rozróżniania nowotworów jelita grubego od innych nowotworów | |
| TNSN08401A1 (en) | Methods of treating diagnosing or detecting cancer | |
| MX2007013727A (es) | Caracterizacion de cancer de prostata. | |
| WO2009085196A8 (en) | Methods and compositions for correlating genetic markers with prostate cancer risk | |
| GB0602992D0 (en) | Methods, genes and proteins | |
| WO2007090125A3 (en) | Prognostic factors for anti-hyperproliferative disease gene therapy | |
| WO2009065511A3 (en) | Methods and nucleic acids for the analysis of gene expression associated with the development of prostate cell proliferative disorders | |
| MX2012000558A (es) | Biomarcador. | |
| GB2480792A (en) | Rapid oligo probes | |
| WO2008112988A3 (en) | Apcdd1 inhibitors for treating, diagnosing or detecting cancer | |
| WO2008100244A3 (en) | Methods of detecting mutations associated with ataxia-ocular apraxia 2 (aoa2) | |
| WO2011130636A3 (en) | Methods and compositions for identifying mutations in cancer related genes | |
| WO2007107996A3 (en) | Novel nucleotide and amino acid sequences and methods of use thereof for diagnosis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| HH | Correction or change in general | ||
| FG | Grant or registration |